News
Hosted on MSN14d
Healios KK Advances Global Phase 3 Trial for ARDS TreatmentHealios KK ( (JP:4593)) has issued an update. Healios KK has completed regulatory consultations in Japan for its investigational ARDS treatment and is preparing for a global Phase 3 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback